Prospective evaluation of catheter ablation in patients with implantable cardioverter defibrillators and multiple inappropriate ICD therapies due to atrial fibrillation and type I atrial flutter

被引:12
作者
Korte, T [1 ]
Niehaus, M [1 ]
Meyer, O [1 ]
Tebbenjohanns, J [1 ]
机构
[1] Hannover Med Sch, Dept Cardiol & Angiol, D-30625 Hannover, Germany
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2001年 / 24卷 / 07期
关键词
implantable cardioverter defibrillator; catheter ablation; atrial fibrillation; type I atrial flutter;
D O I
10.1046/j.1460-9592.2001.01061.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The high incidence of inappropriate therapies due to drug refractory supraventricular tachycardia remains a major unsolved problem of the ICD. Most of the inappropriate therapies for supraventricular tachycardia are caused by AF and type I atrial flutter with rapid ventricular response. The purpose of this prospective study was to determine the usefulness of AVN modulation or ablation for rapid AF and ablation of the tricuspid annulus-inferior vena cava (TA-IVC) isthmus for type I atrial flutter in ICD patients with frequent inappropriate ICD interventions. Eighteen consecutive patients were enrolled in this study. Twelve patients received a mean of 34 +/- 36 antitachycardia pacing (ATP) and 41 +/- 32 shock therapies for rapid AF during 49 +/- 39 months, and 6 patients a mean of 111 +/- 200 ATP and 11 +/- 8 shock therapies for type I atrial flutter during 52 +/- 37 months preceding ablation procedure. Modification of the AVN was successful in 10 (83%) of 12 AF patients, in 2 (17%) patients ablation of the AVN was performed. A complete TA-IVC isthmus block was achieved in 5 (83%) of 6 a trial flutter patients. Three (25%) AF patients had 11 +/- 24 recurrences of ATP and 0.4 +/- 1.1 shock therapies for rapid AF during 15 +/- 7 months. None of the atrial flutter patients had recurrences of inappropriate therapies for type I atria] flutter during 14 +/- 8 months, but two (33%) patients had inappropriate ICD therapies for type II atrial flutter or rapid AF. There was an overall mean incidence of 18 +/- 22 inappropriate ICD therapies per 6 months before and 4 +/- 9 per 6 months after the ablation procedure (P < 0.05). In conclusion, radiofrequency catheter modification or ablation of the AVN for rapid AF and ablation for atrial flutter type I are demonstrated to be highly effective in the majority of ICD patients with drug refractory multiple inappropriate ICD therapies.
引用
收藏
页码:1061 / 1066
页数:6
相关论文
共 23 条
[1]   ELECTROCARDIOGRAPHICALLY DOCUMENTED UNNECESSARY, SPONTANEOUS SHOCKS IN 241 PATIENTS WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATORS [J].
GRIMM, W ;
FLORES, BF ;
MARCHLINSKI, FE .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (11) :1667-1673
[2]  
HOOK BG, 1991, J AM COLL CARDIOL, V17, P985
[3]   HIS-BUNDLE ABLATION FOR SUPRAVENTRICULAR ARRHYTHMIAS TO AVOID SPURIOUS SHOCKS OF AN IMPLANTED DEFIBRILLATOR [J].
JORDAENS, L ;
CAENEPEEL, A ;
CALLE, P .
CLINICAL CARDIOLOGY, 1992, 15 (09) :693-695
[4]   A new classification algorithm for discrimination of ventricular from supraventricular tachycardia in a dual chamber implantable cardioverter defibrillator [J].
Korte, T ;
Jung, W ;
Wolpert, C ;
Spehl, S ;
Schumacher, B ;
Esmailzadeh, B ;
Lüderitz, B .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1998, 9 (01) :70-73
[5]   Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing [J].
Kühlkamp, V ;
Dörnberger, V ;
Mewis, C ;
Suchalla, R ;
Bosch, RF ;
Seipel, L .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1999, 10 (07) :905-915
[6]   Preliminary clinical experience with the first dual chamber pacemaker defibrillator [J].
Lavergne, T ;
Daubert, JC ;
Chauvin, M ;
Dolla, E ;
Kacet, S ;
Leenhardt, A ;
Mabo, P ;
Ritter, P ;
Sadoul, N ;
Saoudi, N ;
Henry, C ;
Nitzsche, R ;
Ripart, A ;
Murgatroyd, F .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1997, 20 (01) :182-188
[7]   Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation [J].
Morady, F ;
Hasse, C ;
Strickberger, SA ;
Man, KC ;
Daoud, E ;
Bogun, F ;
Goyal, R ;
Harvey, M ;
Knight, BP ;
Weiss, R ;
Bahu, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (01) :113-121
[8]   Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia [J].
Moss, AJ ;
Hall, WJ ;
Cannom, DS ;
Daubert, JP ;
Higgins, SL ;
Klein, H ;
Levine, JH ;
Saksena, S ;
Waldo, AL ;
Wilber, D ;
Brown, MW ;
Heo, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1933-1940
[9]   Role of the tricuspid annulus and the eustachian valve/ridge on atrial flutter - Relevance to catheter ablation of the septal isthmus and a new technique for rapid identification of ablation success [J].
Nakagawa, H ;
Lazzara, R ;
Khastgir, T ;
Beckman, KJ ;
McClelland, JH ;
Imai, S ;
Pitha, JV ;
Becker, AE ;
Arruda, M ;
Gonzalez, MD ;
Widman, LE ;
Rome, M ;
Neuhauser, J ;
Wang, XZ ;
Calame, JD ;
Goudeau, MD ;
Jackman, WM .
CIRCULATION, 1996, 94 (03) :407-424
[10]   Radiofrequency ablation of atrial flutter and atrial tachycardias in patients with permanent indwelling catheters [J].
Newby, KH ;
Zimerman, L ;
Wharton, JM ;
Kent, V ;
Kearney, M ;
Brandon, MJ ;
Natale, A .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1996, 19 (11) :1612-1617